1. Home
  2. MLAB vs YDES Comparison

MLAB vs YDES Comparison

Compare MLAB & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

HOLD

Current Price

$107.00

Market Cap

533.0M

Sector

Industrials

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$4.37

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLAB
YDES
Founded
1982
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
533.0M
543.0M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
MLAB
YDES
Price
$107.00
$4.37
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$94.00
N/A
AVG Volume (30 Days)
114.9K
4.8K
Earning Date
05-27-2026
05-12-2026
Dividend Yield
0.67%
N/A
EPS Growth
99.24
N/A
EPS
1.95
N/A
Revenue
N/A
N/A
Revenue This Year
$6.07
N/A
Revenue Next Year
$5.41
N/A
P/E Ratio
$54.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.63
$4.37
52 Week High
$111.29
$25.00

Technical Indicators

Market Signals
Indicator
MLAB
YDES
Relative Strength Index (RSI) 58.94 31.36
Support Level $94.01 N/A
Resistance Level $107.88 $5.36
Average True Range (ATR) 5.12 0.25
MACD 0.19 -0.00
Stochastic Oscillator 70.61 0.03

Price Performance

Historical Comparison
MLAB
YDES

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: